Veery Capital, LLC

Position in MRK — Merck & Co., Inc.

CIK 1844375 Wilmington, DE

Position in MRK

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$342,324

+$21,511 QoQ

Shares Held

2,664

-0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.84%

of 13F equity value

Holder Rank

#3,051

of 3,769 holders

Holding Since

Mar 2022

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Veery Capital, LLC holds $1,998,644 across 6 Drug Manufacturers - General names. MRK ranks #3 (17.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,691	$429,463
2	LLY	ELI LILLY & Co	308	$369,424
3	MRK	Merck & Co., Inc. This page	2,664	$342,324
4	AZN	Astrazeneca PLC	1,787	$338,850
5	GILD	Gilead Sciences, Inc.	2,330	$294,372
6	ABBV	AbbVie Inc.	891	$224,211

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$342,324	2,664	-0.1%	Shares	Sole	2026-07-09
2026-03-31	$320,813	2,667	+0.6%	Shares	Sole	2026-04-09
2025-12-31	$278,939	2,650	+2.0%	Shares	Sole	2026-01-27
2025-09-30	$218,050	2,598	+0.2%	Shares	Sole	2025-10-15
2025-06-30	$205,182	2,592	-3.8%	Shares	Sole	2025-07-07
2025-03-31	$241,813	2,694	-4.7%	Shares	Sole	2025-04-08
2024-12-31	$281,229	2,827	-6.3%	Shares	Sole	2025-01-15
2024-09-30	$342,496	3,016	-0.4%	Shares	Sole	2024-11-06
2024-06-30	$374,866	3,028	-1.8%	Shares	Sole	2024-07-18
2024-03-31	$406,669	3,082	+0.5%	Shares	Sole	2024-04-19
2023-12-31	$334,473	3,068	-1.6%	Shares	Sole	2024-01-10
2023-09-30	$321,101	3,119	-1.0%	Shares	Sole	2023-10-13
2023-06-30	$363,593	3,151	+3.2%	Shares	Sole	2023-07-13
2023-03-31	$324,702	3,052	+20.0%	Shares	Sole	2023-04-13
2022-12-31	$282,145	2,543	-2.0%	Shares	Sole	2023-01-17
2022-09-30	$223,395	2,594	-3.6%	Shares	Sole	2022-10-12
2022-06-30	$245,338	2,691	-4.9%	Shares	Sole	2022-07-18
2022-03-31	$232,201	2,830	—	Shares	Sole	2022-04-18
No filing history on record for this holder in this stock.